Ansell (ASX:ANN) Accumulated Depreciation: A$0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:ANN Ansell Ltd ASX:ANN
76 GF Score
Price A$33.64
GF Value A$29.45
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Ansell Accumulated Depreciation?

Ansell ASX:ANN +2.94% 76 Accumulated Depreciation is A$0 Mil as of Dec. 2025. GuruFocus rates ASX:ANN with a GF Score™ of 76/100 and a GF Value™ of A$29.45 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Ansell's quarterly accumulated depreciation increased from Dec. 2024 (A$0 Mil) to Jun. 2025 (A$-870 Mil) but then stayed the same from Jun. 2025 (A$-870 Mil) to Dec. 2025 (A$0 Mil).

Ansell's annual accumulated depreciation increased from Jun. 2023 (A$-729 Mil) to Jun. 2024 (A$-778 Mil) and increased from Jun. 2024 (A$-778 Mil) to Jun. 2025 (A$-870 Mil).

Ansell Accumulated Depreciation Related Terms

Ansell Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Ansell's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ansell Accumulated Depreciation Chart

Ansell Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -563.49 -652.45 -728.61 -777.70 -869.84

Ansell Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -777.70 0.00 -869.84 0.00
ASX:ANN
76GF Score
Ansell Ltd ASX:ANN
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ansell Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of A$0 Mil mean?
Ansell (ASX:ANN) has a Accumulated Depreciation of A$0 Mil as of Dec. 2025. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Ansell and its competitors.
Is Ansell's Accumulated Depreciation too high?
Ansell's current Accumulated Depreciation is A$0 Mil. Overall, Ansell has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ansell's Accumulated Depreciation compare to ISRG and BDX?
Ansell's Accumulated Depreciation of A$0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Medical Devices & Instruments company?
A good Accumulated Depreciation depends on the Medical Devices & Instruments industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Ansell and its competitors. Ansell's current Accumulated Depreciation is A$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ansell stock overvalued right now?
Based on GuruFocus' analysis, Ansell (ASX:ANN) is currently considered Modestly Overvalued. The stock's GF Value™ is A$29.45, compared to a current price of A$33.64 — trading 14.2% above its estimated fair value. The current Accumulated Depreciation is A$0 Mil. Ansell's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Ansell (ASX:ANN), the current Accumulated Depreciation is A$0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ansell (ASX:ANN) Overvalued in 2026?

Based on GuruFocus' analysis, Ansell stock appears to be overvalued. The current stock price of A$33.64 is trading 14.2% above its estimated GF Value™ of A$29.45. GuruFocus considers Ansell to be Modestly Overvalued.

Key valuation signals for ASX:ANN:

  • Accumulated Depreciation: A$0 Mil
  • GF Value™: A$29.45 vs. price of A$33.64 (14.2% above fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the ASX:ANN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ansell Business Description

Address 678 Victoria Street, Level 3, Richmond, Melbourne, VIC, AUS, 3121
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 55% of revenue and operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents, and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly. Largest sales regions are North America and Europe, Middle East, and Africa. Asia-Pacific and Latin America, combined, are about one-fourth of sales.
76GF Score

Get the complete analysis for ASX:ANN

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$33.64
Price
A$29.45
GF Value